Loading
Walgreens Boots Alliance, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 15 Apr 2024.
Walgreens Boots Alliance, Inc.: what insiders have been doing
Every trade that managers of Walgreens Boots Alliance, Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Healthcare & Pharma sector and is based in Deerfield, United States. It was founded in 2015. The past year has been quiet: not a single insider filing for Walgreens Boots Alliance, Inc. The previous disclosure was published on 28 August 2025.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
135
Thresholds
n/a
Buy Volume
€920,275
7 ops. · all time
Sell Volume
€32M
17 ops. · all time
Who traded when
BuySaleStefano Pessina1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended August 2024 · cache
Income statement
RevenueUS$127.1B
Gross profitUS$22.8B18% margin
Net income-US$7.4B-5.8% margin
Last declaration on 28 August 2025
Declarations135 total
348,093 sharesCommon StockSEC:0001193125-25-191100:0
124,670 sharesCommon StockSEC:0000950170-25-111924:0
414,273 sharesCommon StockSEC:0000950170-25-111923:0
1,332,014 sharesCommon StockSEC:0000950170-25-111920:0
93,037 sharesCommon StockSEC:0000950170-25-111919:0
494,295 sharesCommon StockSEC:0000950170-25-111917:0
303,875 sharesCommon StockSEC:0000950170-25-111911:0
348,051 sharesCommon StockSEC:0000950170-25-111907:0
145,444 sharesCommon StockSEC:0000950170-25-111906:0
969,057 shares@ US$11.4599.2% of flowCommon Stock, par value $0.01 per shareSEC:0000950170-25-111883:0
1,317,544 shares@ US$11.4560.0% of flowCommon Stock, par value $0.01 per shareSEC:0000950170-25-111882:0
16,820 shares0Common StockSEC:0001618921-25-000088:0
11,774 shares0Common StockSEC:0001618921-25-000082:0
16,820 shares0Common StockSEC:0001618921-25-000077:0
40,304 shares@ US$11.235100.0% of flowCommon StockSEC:0001618921-25-000048:0
16,495 shares@ US$11.235100.0% of flowCommon StockSEC:0001618921-25-000047:0
19,135 shares@ US$11.235100.0% of flowCommon StockSEC:0001618921-25-000050:0
832,258 shares@ US$11.0191.6% of flowCommon Stock, par value $0.01 per shareSEC:0001554687-25-000001:0
1,354 shares@ US$11.23100.0% of flowCommon StockSEC:0001618921-25-000025:0
10,706 shares@ US$11.2351.7% of flowCommon StockSEC:0001618921-25-000026:0
1,741 shares@ US$11.23100.0% of flowCommon StockSEC:0001618921-25-000027:0
1,545 shares@ US$11.23100.0% of flowCommon StockSEC:0001618921-25-000023:0
762,032 shares0Common StockSEC:0001618921-24-000144:0
72,193 shares0Common StockSEC:0001618921-24-000140:0
256,684 shares0Common StockSEC:0001618921-24-000142:0
25 of 135 declarations
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. (WBA) is a major health-care and pharmacy retail platform with a long operating history in the United States and internationally. The stock was historically listed on the U.S. NASDAQ market (United States), and the company became an especially important reference point for investors following its 2025 take-private transaction. For market analysis purposes, WBA remains a useful case study in U.S. pharmacy retail, prescription services, and health-and-wellness distribution.
The business traces its roots to Walgreens, founded in the early 20th century, and later expanded through the combination with Alliance Boots. That transaction created a larger pharmacy-led health and beauty group with a broader geographic footprint and a more diversified operating model. The company’s historical headquarters and operational base were in the Chicago area, specifically Deerfield, Illinois, reinforcing its identity as a U.S.-anchored company with international reach.
Read moreShow less
WBA’s core activities have centered on retail pharmacy, prescription fulfillment, health services, specialty pharmacy, home delivery, and the sale of front-of-store consumer categories such as beauty, personal care, and wellness products. In the international business, Boots has been a flagship brand in the UK and Ireland, while the broader group also maintained pharmacy and wholesale-related operations in selected overseas markets. This mix of customer-facing retail, medication dispensing, and health-oriented services gave WBA a hybrid profile that blended consumer exposure with regulated health-care economics.
From a competitive standpoint, Walgreens has long been one of the most recognizable pharmacy chains in the United States, benefiting from a large store network, strong brand awareness, and deep local presence. Its competitive strength historically came from convenient access, recurring prescription traffic, and a broad role in everyday health care. At the same time, the company has faced intense pressure from CVS, mass merchants, grocery chains, mail-order pharmacy, digital competitors, and ongoing reimbursement compression in the U.S. pharmacy market.
Recent developments indicate a company in transition. Management communications in 2025 and 2026 emphasized simplifying the organization, refocusing on pharmacy excellence, and strengthening the core retail pharmacy proposition. The company has also highlighted services linked to specialty pharmacy and GLP-1 weight-management support, underscoring the strategic push toward higher-value health services. Another important recent factor for investors is the wave of SEC Form 4 insider filings associated with the 2025 change-of-control and privatization process, which can materially affect how insider transactions are interpreted. Overall, WBA has moved from being a large public pharmacy retailer to a transformed health-care asset shaped by restructuring, portfolio simplification, and ownership change.
